LUC7L3 and hepatocellular carcinoma: However, for patients with early-stage HCC (Jiang’s cohort), the prognostic stratification ability of LUC7L3 is much better than that of AFP, indicating that LUC7L3 is beneficial for the prognostic diagnosis of HCC patients, especially for early-stage HCC.